Beijing Scitop Bio-tech Co., Ltd.

XSEC:300858 Stock Report

Market Cap: CN¥4.0b

Beijing Scitop Bio-tech Past Earnings Performance

Past criteria checks 2/6

Beijing Scitop Bio-tech's earnings have been declining at an average annual rate of -0.02%, while the Food industry saw earnings growing at 2.5% annually. Revenues have been declining at an average rate of 1.4% per year. Beijing Scitop Bio-tech's return on equity is 5.3%, and it has net margins of 30.8%.

Key information

-0.02%

Earnings growth rate

-10.0%

EPS growth rate

Food Industry Growth7.2%
Revenue growth rate-1.4%
Return on equity5.3%
Net Margin30.8%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Beijing Scitop Bio-tech makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

XSEC:300858 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24301936234
30 Jun 24297975735
31 Mar 24286925736
31 Dec 23299936034
30 Sep 23322956230
30 Jun 233521056226
31 Mar 233551065921
01 Jan 233691105822
30 Sep 223601115523
30 Jun 223541106124
31 Mar 223701116528
31 Dec 213651106427
30 Sep 213641095626
30 Jun 213661035323
31 Mar 213611034621
31 Dec 20339974018
30 Sep 20334994119
30 Jun 20313923818
31 Mar 20315954518
31 Dec 19308933915
30 Jun 19305903714
31 Mar 19296842813
01 Jan 19318923616
31 Dec 17284713113
31 Dec 1626112819
31 Dec 1518535196

Quality Earnings: 300858 has high quality earnings.

Growing Profit Margin: 300858's current net profit margins (30.8%) are higher than last year (29.6%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 300858's earnings have declined by 0.02% per year over the past 5 years.

Accelerating Growth: 300858's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 300858 had negative earnings growth (-2.7%) over the past year, making it difficult to compare to the Food industry average (-5.8%).


Return on Equity

High ROE: 300858's Return on Equity (5.3%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 18:13
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Beijing Scitop Bio-tech Co., Ltd. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Wendan WangChina International Capital Corporation Limited
Wende WuTianfeng Securities Brokerage Co., Ltd